Nvidia is reportedly developing a specialized processor aimed at accelerating AI inference, a move that could reshape how ...

Lightbits Labs Ltd. today is introducing a new architecture aimed at addressing one of the most stubborn bottlenecks in large-scale artificial intelligence inference: the growing mismatch between the ...

ScaleFlux, FarmGPU, and Lightbits Labs today announced the public debut of a collaborative architecture designed to solve one of AI inference's most persistent challenges: the memory and I/O ...

Nvidia's upcoming GTC conference will reveal CEO Jensen Huang's AI hardware, software, and partnership plans. Investors ...

(PDF file) https://storage.googleapis.com/aviary-public/ether0_preprint.pdf Inference models such as OpenAI o3 and Claude Opus 4 can score higher than humans in ...

Researchers present NorthPole – a brain-inspired chip architecture that blends computation with memory to process data efficiently at low-energy costs. Since its inception, computing has been ...

SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform.

Inference protection is a preventive approach to LLM privacy that stops sensitive data from ever reaching AI models. Learn how de-identification enables secure, compliant AI workflows with ...